Active Shortage

PRO-GABAPENTIN

PRO DOC LIMITEE

View this drug's full profile page →

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of PRO-GABAPENTIN in Canada?

Yes. PRO-GABAPENTIN 800MG has an active shortage reported to Health Canada (last updated August 28, 2026).

Why is PRO-GABAPENTIN not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will PRO-GABAPENTIN be available again?

The manufacturer's estimated resolution date is January 27, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file6 products · 1 same form & route

Expected resolution~2 months remaining (estimate)

Affected strength800MG

Report last updated2026-08-28

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

AURO-GABAPENTIN TABLETS

AURO PHARMA INC

800MG · DIN 02428342

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

PMS-GABAPENTIN

PHARMASCIENCE INC

400MG · DIN 02243448

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

GABAPENTIN

SIVEM PHARMACEUTICALS ULC

300MG · DIN 02246315

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

TEVA-GABAPENTIN

TEVA CANADA LIMITED

100MG · DIN 02244513

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

AURO-GABAPENTIN

AURO PHARMA INC

300MG · DIN 02321211

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

RIVA-GABAPENTIN

LABORATOIRE RIVA INC.

100MG · DIN 02251167

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Estimated Resolution

2027-01-27

~2 months remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02310481

Strength

800MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

GABAPENTIN

Tier

Unrated

Last Updated

2026-08-28

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from PRO DOC LIMITEE

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACEBUTOLOL - 400

400MG · DIN 02164426

100MG · DIN 02164396

200MG · DIN 02164418

ACETAMINOPHENE 325TAB

325MG · DIN 00382752

ACETAMINOPHENE 500TAB

500MG · DIN 00386626

70MG · DIN 02303078

10MG · DIN 02414759

ALLOPURINOL-100

100MG · DIN 00555681

ALLOPURINOL-200

200MG · DIN 02130157

ALLOPURINOL-300

300MG · DIN 00555703

12.5MG · DIN 02424029

DIN 00870943